COMPANY
New Life Pharma LLC
New Life Pharma LLC: warning letter recipient, recalling firm for Semaglutide, Tirzepatide, as stated by public registers.
WARNING LETTER RECIPIENT
Received an FDA warning letter naming the peptide.
| Semaglutide | CGMP/Adulterated and Unapproved New Drug/Misbranded, 2026-04-14 Regulator FDA warning letters |
|---|---|
| Tirzepatide | CGMP/Adulterated and Unapproved New Drug/Misbranded, 2026-04-14 Regulator FDA warning letters |
RECALLING FIRM
Recalled a product naming the peptide (FDA enforcement report).
| Semaglutide | Class II recall, Ongoing, 2026-03-11 Regulator openFDA |
|---|---|
| Tirzepatide | Class II recall, Ongoing, 2026-03-11 Regulator openFDA |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.